Vertex Pharmaceuticals Inc (VRTX)

Debt-to-capital ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	16,409,600	17,580,400	13,912,700	10,100,000	8,686,800
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $16,409,600K)
= 0.00

The debt-to-capital ratio of Vertex Pharmaceuticals Inc for the years ending December 31, 2020 to December 31, 2024, remained consistently low at 0.00. This indicates that the company has not used debt significantly to finance its operations relative to its total capital structure. A low debt-to-capital ratio is generally considered favorable as it signifies lower financial risk and potential for financial stability. Vertex Pharmaceuticals Inc's consistent 0.00 debt-to-capital ratio suggests a prudent capital structure management strategy focused on minimizing debt exposure in relation to total capital employed.